000			03166nam a22003975i 4500
001			85965
003			ES-MaUEC
005			20230207040536.0
007			cr nn 008mamaa
008			160506s2016 gw a s 000 0 eng d
020			_a9783319329499
024	7		_a10.1007/978-3-319-32949-9 _2doi
040			_aES-MaUEC
050		4	_aRM300 _b.H67 2016 EB
082	0	4	_a572.6
245	0	0	_aHost Defense Peptides and Their Potential as Therapeutic Agents _cedited by Richard M Epand
264		1	_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (X, 321 p.) _b41 ilustraciones, 32 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aDiversity in Host Defense Antimicrobial Peptides -- Antifungal Host Defense Peptides -- Antiviral Host Defense Peptides -- Anticancer peptides: prospective innovation in cancer therapy -- Plant Antimicrobial Peptides -- Host Defense Peptides and the Eicosanoid Cascade -- Bacterial resistance to host defence peptides -- Engineered OAKs Against Antibiotic Resistance and for Bacterial Detection -- Structural Analysis of Amphibian, Insect and Plant Host Defense Peptides Inspires the Design of Novel Therapeutic Molecules -- How to teach old antibiotics new tricks -- Antimicrobial peptides and Preterm Birth -- Host defense peptides and their advancements in translational Staphylococcus aureus research.
520	3		_aThis book offers an overview of our current understanding of host defense peptides and their potential for clinical applications as well as some of the obstacles to this. The chapters, written by leading experts in the field, detail the number and diversity of host defense peptides, and discuss the therapeutic potential not only of antibacterial, but also of antifungal, antiviral, plant antimicrobial and anticancer host defense peptides. The authors provide new insights into their mechanisms of action and their immunomodulatory properties, and review recent advances in the design of novel therapeutic molecules. Lastly, their potential to prevent preterm births and Staphylococcus aureus infections is highlighted. The book is of interest to researchers, industry and clinicians alike.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGER
650		7	_aFarmacología _0comprobar BNE19900953030 _2embne _9137893
650		7	_aInmunología _0comprobar BNE19900958507 _2embne _9138330
650		7	_9137892 _aMedicamentos _0comprobar BNE19900953029 _2embne
700	1		_aEpand, Richard M. _eeditor literario _999318 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-32949-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319329499
907			_a.b12952436 _b10-10-17 _c21-11-16
998			_am _a_alco _a_vill _b23-09-17 _cm _dz _ei _feng _ggw _h0
945			_aRM300 H67 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11595127 _z06-04-17
999			_c85965 _d85965 _x1